NCT lookup
Pull any trial record directly from ClinicalTrials.gov.
Vibrotactile Stimulation for Parkinson's Disease
Vibrotactile Stimulation for Parkinson's Disease
CompletedEARLY_Phase 1
Sponsor: University of Colorado, Denver
Conditions: PARKINSON DISEASE (Disorder)
Interventions: Vibrotactile stimulation
Countries: United States
Investigation on whether and how vibrotactile stimulation applied on the fingertips affects beta power in the subthalamic nucleus.
Eligibility overview
Sex: ALL
Age: 18 Years to 85 Years
Healthy volunteers: No
Study type: INTERVENTIONAL
Eligibility criteria
Inclusion Criteria: * The population to be enrolled will be between 18 and 85 years of * Have a diagnosis of idiopathic Parkinson's disease, determined by a movement disorders neurologist at the CU Movement Disorders Center * Has undergone deep brain stimulation surgery at the University of Colorado hospital Exclusion Criteria: * have severe sensory abnormalities of the fingertips such as vibratory urticaria * Patients that cannot clearly communicate with staff and speak English * Patients that are on psychoactive or narcoleptic medications, medications that affect brain function or alter EEG recorded activity (i.e., anticonvulsants, ADHD, depression, or anxiety medication) * Participation in another drug, device, biologic, or intervention trial concurrently or within the preceding 30 days.
Locations (1)
- Denver, Colorado, United States